Skip to main content
Evrofarma S.A. logo

Evrofarma S.A. — Investor Relations & Filings

Ticker · EVROF ISIN · GRS385113006 LEI · 213800A8PXGBSRJIEH28 AT Manufacturing
Open in API
Filings indexed 14 across all filing types
Latest filing 2026-04-24 Transaction in Own Shar…
Country GR Greece
Listing AT EVROF

About Evrofarma S.A.

https://evrofarma.gr/

Evrofarma S.A. is a company engaged in the production and trade of dairy products. Its product portfolio includes a variety of milk, such as goat and Jersey milk, yogurt, and a range of cheese products made from both cow and goat milk. The company also produces fermented beverages. Evrofarma sources milk from its network of associated farmers, contributing to the local agricultural economy. In addition to its dairy operations, the company is involved in the trade of animal feed and livestock. Its facilities utilize a state-of-the-art anaerobic treatment system for waste management.

Recent filings

Filing Released Lang Actions
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΑΠΟΚΤΗΣΗ Ή ΜΕΤΑΒΙΒΑΣΗ ΙΔΙΩΝ ΜΕΤΟΧΩΝ
Transaction in Own Shares Classification · 1% confidence The document is a company announcement in Greek titled "Ανακοίνωση Απόκτησης Ιδίων Μετοχών" which translates to "Announcement of Acquisition of Own Shares." It details the number of own shares purchased, transaction dates, average price, total value, and resulting holdings. This exactly matches the definition for a Transaction in Own Shares (Code: POS).
2026-04-24 Greek (modern)
Οικονομική έκθεση ΕΒΡΟΦΑΡΜΑ Α.Ε. (2025,Ετήσιος ισολογισμός,Ενοποιημένη)-iXBRL
Annual Report (ESEF) Classification · 1% confidence FY 2025
2026-04-17 Greek (modern)
Δελτίο Τύπου 17.04.26
Earnings Release Classification · 1% confidence The document is a press release in Greek from Evrofarma announcing consolidated financial results for the year ended December 31, 2025. It provides key highlights (revenues, net profit, EBITDA, margins) and mentions a dividend proposal. It is short (3,363 characters) and summarizes results rather than presenting the full annual report. This matches an Earnings Release (ER). FY 2025
2026-04-17 Greek (modern)
Οικονομικό Ημερολόγιο 2026
Report Publication Announcement Classification · 1% confidence The document is an “Οικονομικό Ημερολόγιο 2026,” i.e., the company’s financial calendar listing dates for the press release of 2025 annual results, announcement of the annual report, AGM, dividend record date and payment, and H1 report. It does not contain the actual financial data but announces the timing of future report publications and corporate events. This fits the “Report Publication Announcement” (RPA) category, which covers announcements regarding the timing or release of reports.
2026-04-01 Greek (modern)
Financial Calendar 2026
Report Publication Announcement Classification · 1% confidence The document is a press release announcing key future dates in the financial calendar (publication of annual and semi-annual reports, AGM, ex-dividend and payment dates). It does not contain the reports themselves but schedules their release, matching the definition of a Report Publication Announcement.
2026-04-01 English
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΑΠΟΚΤΗΣΗ ΙΔΙΩΝ ΜΕΤΟΧΩΝ
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from Evrofarma regarding the acquisition of its own shares (share buyback) on the Athens Stock Exchange between 09.03.2026 and 13.03.2026. It details the number of shares, average prices, and total value, citing compliance with EU Regulation 596/2014. This fits the definition of 'Transaction in Own Shares' (POS).
2026-03-13 Greek (modern)

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.